Evommune, Inc.
EVMN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002044725
In the last 90 days, Evommune, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $462.5M in total; no superinvestor holds it.
Members of Congress who traded EVMN
No member of Congress has reported a trade in Evommune, Inc. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.